Everolimus Reduces Breast Cancer Treatment Effects in Bone Clinical Endocrinology News Digital Network Adding everolimus to exemestane for the treatment of estrogen receptorāpositive advanced breast cancer that is refractory to nonsteroidal aromatase inhibitors has beneficial effects on bone turnover and breast cancer progression in bone, according to ... |
